Replies to post #446429 on Anavex Life Sciences Corp (AVXL)

[bas2020]

Not a waste of time if the FDA is impressed by the complete package of trial data, OLE and RWE evidence. Agree... AD is priority #1, but that doesn't mean drop Rett.